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Abstract
Background: In 2009, the Dutch Health Care Inspectorate (IGZ) observed several serious risks to safety involving
medication within elderly care facilities. However, by 2011, high risks had been reduced in almost all the organisations
we visited. And yet the IGZ analysed too the alarming increase in the number of incidents arising in the self-reported
national indicator of medication safety between 2009 and 2010. The aim of this study was to understand the factors
that can explain this contradiction between the increase in self-reported medication incidents and the observation of
the IGZ in reducing the risks to medication safety through supervision.
Methods: We interviewed health care professionals of ten care facilities, visited by the IGZ, who were involved in, or
responsible for, the improvement of medication safety in their institutions. As outcome measures we used the rate of
medication safety risk per facility; the perceptions of the participant with regard to the reports of medication incidents;
the level of medication safety of the facility; the measures used to improve medication safety; and the supervision of
medication safety.
This was a mixed methods study, qualitative in that we used semi-structured interviews, and quantitative, by
calculating risks for the different organisations we visited. The findings from both study methods resulted in a
comprehensive view and an in-depth understanding of this contradiction.
Results: The contradiction between the increase in self-reported medication incidents and the observation of
reduced risks was explained by three themes: activities designed to improve medication safety, the reporting
of medication incidents, and, lastly, the impact of supervision. The focus of the IGZ on issues of medication
safety stimulated most elderly care facilities to reduce medication risks. Also, a change in the culture of reporting incidents
caused an increase in the number of reported incidents.
Conclusions: Supervision contributed to an improvement in actions geared towards reducing the risks associated with
the safety of medication. It also increased a willingness to report such incidents. The more incidents reported are
therefore not necessarily a sign of an increase in the risks, but can also be considered as a sign of a safer culture.
Keywords: Medication safety risks, Medication incident reports, Safety culture, Nursing homes, Elderly, Supervision
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Background
Medication incidents are a major risk to public health
[1]. A secure means of supplying and taking the medica-
tion, such as its safe and appropriate supply and admin-
istration, seems to be a challenge all over the world.
This is especially true for nursing homes and homes for
older people. In Norway, one third of nursing home resi-
dents experienced at least one medication error a year
[2]. In the United Kingdom, this figure was even as high
as two out of three [3].
There are several reasons why the safety of medication
is such a challenge in the care of older people. The first
problem is polypharmacy, that is the use of five or more
medicines. This is reported for 30 to 45% of the older
people. This increases to ten or more medicines for 20%
of the people aged over 75. Research suggests that
among people living in Dutch residential care for older
people 40 % is being over-treated in a sense that too
much medication is prescribed while some medicines
are not or no longer necessary. Avoidable side effects
and adverse interactions between medicines are com-
mon risks for people who are prescribed multiple medi-
cations [4]. Secondly, several medicines are not suitable
for older people because of the patient’s reduced cogni-
tion or metabolic capacity and functioning in many sys-
tems, such as the liver, brain, heart or muscles. Thirdly,
co-morbidity increases the risk of less effective pharma-
ceutical treatment [5].
Errors take place during different stages of the medica-
tion process, from prescribing, preparation and delivery,
to actually taking pills, and the administration involved
surrounding the whole process of medication [6]. There
are several policies to reduce medication errors in nurs-
ing homes and homes for the elderly [7]. For instance,
changing the behaviour of qualified health care profes-
sionals is crucial. This can be achieved in part by record-
ing agreements, adhering to guidelines and protocols,
and through clear communication [8]. Furthermore, ad-
equate introduction of technology, such as systems for
the automated dispensing of medication or electronic
prescribing, play an important role in improving the
processes of medication [9].
The Dutch Health Care Inspectorate (IGZ, see Table 1)
has, since 2009, chosen medication safety as one of the
special topics for its supervision of long-term care for older
people. This is both because of the major risks and the op-
portunities to prevent them. Between May 2009 and
March 2010 the IGZ visited 93 nursing homes and homes
for older people in order to identify possible medication
safety risks. It concluded that significant improvements
were essential. There were several reasons for this view.
There was insufficient consultation between organisations
and pharmacists or general practitioners. Health care pro-
fessionals, in general, lacked the skills and expertise in
relation to medication safety. Finally, many organisations
had no safe medication distribution systems [10].
During follow-up visits in 2011, the IGZ observed that
within a year such high risks had been reduced by almost
all the organisations where the IGZ had identified them
during its previous visits [11]. The IGZ now attempted to
confirm this observation through an analysis of the na-
tional indicator of medication safety incidents over the
years 2007-2012 (see Additional files 1 and 2). The indica-
tor represents the percentage of patients that encountered
a medication incident during the month prior to the
measurement of the indicator. All Dutch nursing homes
and homes for older people are obliged to report this indi-
cator once a year. The indicator is self-reported and the
benchmarked outcomes are reported to all organisations
after correcting for their casemix. The national indicator
of the organisations visited, as well as a benchmark group,
showed an alarming increase of medication safety inci-
dents between 2009 and 2010 as shown in Fig. 1.
This increase seems to contradict the results of the
supervision activities and the conclusions of the the-
matic supervision by the IGZ. One would expect fewer
medication incidents because of the improvements ob-
served in medication safety in the elderly care facilities
visited. We aim in this paper to understand the paradox
posed by the increase in the reports of medication
Table 1 The Dutch Health Care Inspectorate (IGZ)
The Dutch Health Care Inspectorate (IGZ) is an agency of the Ministry of
Health, Welfare and Sport. It is the official regulatory body charged with
supervising the quality and safety of healthcare services, prevention
activities and medical products in the Netherlands. The IGZ has
organised its supervision in several ways in order to ensure compliance
with professional standards and guidelines and to ensure patient safety.
The most important methods are supervision based around incidents
and analyses of various types of risk information, also known as risk-
based supervision.
If risks are identified, then the IGZ visits a nursing home or a home for
older people. This method of supervision consists of general supervision
and, what is defined as thematic supervision. In this case the IGZ
conducts visits to several organisations based on a specific theme
common to the whole sector. This action is the result of research or
incidents such as medication safety. The IGZ then assesses one or more
risks depending on the diversity and severity of the risks identified
within a specific organisation. This assessment is based on reviewing
documents relating to the quality management systems, such as care
protocols and patient files, but also to reviewing the communications
with, for example, care managers, care professionals and patients.
The organisation must then take measures to improve safety and thus
reduce the risks. These improvements and their results must then be
reported to the IGZ. The IGZ will then conduct a follow-up visit to assess
the implementation of the improvement measures. The IGZ is mandated
to use enforcement measures if the organisation does not comply and
there is insufficient faith in the organisation to realise the improvements
in time. For instance, the IGZ can impose intensified supervision of an
organisation. This may involve frequent visits, announced or unannounced,
and consultations with the board. They can involve the organisation as a
whole or just one of its departments. The IGZ can also penalise the
organisation including prohibiting it, temporarily or even permanently
from accepting new patients.
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incidents at the same time as reduction in the risks ob-
served. In addition, we aim to create insight into
whether monitoring the national indicator of medication
safety incidents is an efficient way to identify the impact
of supervision by regulatory bodies such as the IGZ.
Methods
Design
Firstly, we looked at the organisations visited by the IGZ
inspectors within the context of the supervision of medi-
cation safety between 2009 and 2011. We then collected
all their risk calculations. Secondly, we conducted semi-
structured interviews by telephone with the professionals
who were involved in, or responsible for, the improve-
ment of medication safety in the nursing homes and
homes for older people which we selected.
Data collection risk calculations
The homes for older people were visited in 2010. During
the visits, two inspectors supervised 11 medication
themes that may cause risks. These themes were: the
transfer, ordering, monitoring, surveillance, availability,
storage, preparation and dispensing of medication; the
training and competencies of health care professionals;
the quality system; and the handling of medication er-
rors. There was also supervision of additional themes in
nursing homes if deemed applicable. These themes were
the guidelines for the prescription of medication and the
presence of small pharmacies located within the care fa-
cilities but without a pharmacist.
In order to assess the level of medication safety, the IGZ
collected information by reviewing documents relating to
the quality management systems, looked at patient files
and spoke with employees. All the themes were scored
separately for ‘risk’ or ‘no risk’. The IGZ presented the re-
sults in a final report following each visit.
If risks were identified, then the organisation had to
take measures to improve safety which had to be
reported to the IGZ. Moreover, the IGZ conducted a
follow-up visit a year later to assess the implementation
of the improvement measures. These results were also
presented in a report.
The number of medication safety risks observed dur-
ing the visits was contained in these final reports in
2010 and 2011. The authors collected the risks from
these reports and present them in Table 3.
The setting and interviews of the participants
We made a subjective selection of ten of the 93 elderly
care facilities which were visited by the IGZ in 2009-2010
and during the follow-up. We selected organisations
which reported the highest increase in medication inci-
dents per inhabitant in 2011 compared to a year before
and the highest decrease in reports of medication inci-
dents. We used subjective sampling to ensure diversity in
experiences with this risk indicator. We approached the
organisations by letter. Afterwards, we called the organisa-
tions to arrange an appointment for an interview by tele-
phone. Before starting the interview, we informed the
interviewees a second time about what to expect, their
rights and obligations, and explained that they were still
allowed to refuse to participate. One care facility declined
to participate because of a lack of time and a second care
facility was already represented by another location of the
same organisation. Therefore, two other organisations
were invited to participate from the same categories as the
ones which did not want to participate. Finally, the sample
consisted of ten care facilities for older people. There was
no relationship between the researchers and the care orga-
nisations. The number of organisations participating
would be enlarged if the results showed variation. Satur-
ation was reached after ten interviews.
Data collection interviews
We used a semi-structured interview guide (Table 2)
[12]. We performed a literature search for medication
Fig. 1 Percentage of patients that encountered a medication incident in 1 month
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safety and added questions related to supervision activ-
ities in order to develop this interview guide.
One researcher (JAV) interviewed all participants in
October and November 2013. The interviews lasted
from between 15 to 30 min. They were all audio taped
and transcribed verbatim. We performed a member
check, that is we presented the audiotapes to the inter-
viewees in order to correct factual inaccuracies and
allow the participants to reflect and comment on the ac-
curacy and validity of the information. Eventually, all in-
terviews were included in its original form.
The level of risk found in all the organisations was cal-
culated by analysing the reports from the IGZ inspectors.
Analysis of the interviews
The interviews were transcribed and analysed using the
principles of Grounded Theory, a qualitative research
method focusing on the identification of concepts that
emerge from study interviews or observation [13]. Two
researchers coded the transcripts to minimise subjectiv-
ity. The researchers used ATLAS.ti 7 to facilitate the
coding process. Coding is the interpretative process in
which conceptual labels are given to the data [13]. Two
researchers (JAV and SMK) independently analysed the
content of the first three transcripts and, drawing con-
clusions from their observations, identified initial codes
(open coding). We merged codes again into unique
codes and a framework for these codes was developed
for further use (axial coding). JAV analysed the rest of
the transcripts. New codes could then be added to the
coding framework. Saturation was reached after ten in-
terviews. Codes that related to the same phenomenon
were grouped into categories and finally themes were
identified. JAV and SMK discussed categories and
themes and consensus was reached between both re-
searchers. A third, and external, researcher (RBK) was
consulted in order to review the codes, categories and
themes. The COREQ (consolidated criteria for reporting
qualitative research) checklist was used for reporting the
results (see Additional file 3) [14].
Results
Quantitative results
Risks were identified in 2010 in 45% ((52/115)*100) of
all the items assessed. This is shown in Table 3. The in-
dividual results from the ten care facilities which were
visited showed a large variation in the risks observed.
The themes most frequently identified as a risk were: the
monitoring and storage of medication; the training and
competencies of health care professionals; and the hand-
ling of medication errors (see Additional file 4). In 2011,




Table 4 shows the demographic characteristics of the
interviewees.
Analysis
The qualitative analysis of the interviews resulted in
eight categories from which three themes emerged: ac-
tivities designed to improve medication safety; the
reporting of medication incidents; and the impact of
supervision (Table 5).
Table 2 Semi-structured interview guide
Main topics Examples of questions
Medication incident
reports
What is the cause of the increase or decrease
in the number of medication incident reports
within the organisation?
What could explain the national trend showing




What were the main conclusions with regard
to medication safety during the visit of the
IGZ in 2010?




Which measures for improving medication
safety were taken by the organisation in
recent years and why?
Supervision What was the effect of the IGZ’s supervision
on the medication safety level within the
organisation?
Did collaboration with other institutions or
organisations contribute to the improvement
in medication safety and why, or why not?
Table 3 The number of medication safety risks observed during
the visits of the IGZ to the ten elderly care facilities
2010 2011
Organisation Total potential risk themes Risk No risk Risk No risk
1 11 4 7 0 11
2 11 3 8 0 11
3 11 5 6 5 6
4 11 4 7 0 11
5a, b 13 0 13 - -
6a 12 11 1 8 4
7 11 8 3 2 9
8 11 7 4 0 11
9c 11 4 7 - -
10a 13 6 7 1 12
Total 115 52 63 20 95
anursing homes; up to two extra themes were supervised
bno risks, so follow-up visits were not needed
cimprovement activities were demonstrated to the IGZ, and so, a follow-up
visit did not take place
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Theme 1: Activities designed to improve medication safety
This theme is divided into three categories: (1) the im-
provements made based on the IGZ visits; (2) the im-
provements made based on the organisation taking its
own initiative; (3) the improvements made through col-
laboration with third parties.
Improvements made based on the IGZ visits
Nursing homes and homes for older people reported hav-
ing made several improvements based on the conclusions
of the first visit of the IGZ. Frequently recurring themes
during the interviews were: the investment in employee
training in medication safety; the introduction of coloured
jackets with a ‘do not disturb’ logo worn by care profes-
sionals during their distribution and dispensing of medica-
tion; and the introduction of double - checks during the
distribution and dispensing of medication which was
not packed by an automated medication dispensing sys-
tem. Medication working groups were also established,
who were responsible too for pharmacotherapeutic and
pharmacy consultations. Finally, small pharmacies lo-
cated within care facilities but without a pharmacist
were closed down.
Improvements made based on the organisation taking its
own initiative
Care facilities also made agreements with pharmacies
and achieved a transition to automated medication dis-
pensing systems and electronic prescribing. Further-
more, most of the interviewees emphasised that they
had started to organise routine internal audits. Based
on these audits, they started to review medication
safety protocols.
Improvements made through collaboration with third
parties
Care facilities used the internal audit data in a variety of
ways. Firstly, for achieving improvements in medication
safety, secondly for external audits or accreditations and,
finally, for external reporting to, for example, health in-
surance companies and the IGZ. These audits often took
place in collaboration with pharmacies and hospital
pharmacies. In addition, organisations asked research in-
stitutes to support them in improving medication safety
by means of staff training, risk- and improvement man-
agement and calamity evaluation. Care facilities referred
to professional standards and guidelines in order to re-
view their medication safety protocols.
Theme 2: The reporting of medication incidents
The three categories related to this theme which
emerged were: (1) the internal causes of increased re-
ports; (2) the internal causes of fewer reports; (3) the na-
tional causes of increased reports.
The internal causes of increased reports
All the interviewees agreed that the focus on medication
safety caused a change in the culture of reporting. This
focus was not only achieved by the visits of the IGZ but
also by the attention given by patient organisations and
health insurers. Health care professionals started to real-
ise that reported incidents were not used for punish-
ment, but rather to provide input for improvements.
The internal causes of fewer reports
All interviewees shared the opinion that many errors
during the preparation, distribution and dispensing of
medication were prevented. The simplification of the
preparation, distribution and dispensing process was
considered to be crucial. For example, care facilities
which showed a decrease in the registration of medica-
tion incident reports said that the main cause of the de-
cline was the automation of the medication process by
introducing an automated medication dispensing system.
The national causes of increased reports
As mentioned before, the increased attention to medica-
tion safety has increased an awareness of the relevance
of analysing incidents and improving care processes in
order to prevent incidents from occurring. The inter-
viewees believed that this increased the willingness to re-
port and consequently the number of medication
incidents reported. It was also was noted that the grow-
ing complexity of health care and its processes could be
responsible for the increased number of medication inci-
dents reported.
Table 4 Demographic characteristics of the participants
Respondent Sex Profession Involved in visits? Yes/No
1 F Care Manager Ya
2 F Pharmacist Y
3 F Policy advisor N
4 M Care Manager N
5 F Policy maker Ya
6 F Nurse Ya
7 F Location manager Y
8 F Nurse Y
9 F Medical director Y
10 M Medical director N
aThe participants were not present during the visits by the IGZ. However, the
participants received feedback after the visit and were responsible for taking
safety improvement measures and/or reporting the improvement activities
and results to the IGZ
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Table 5 Themes, categories, codes and quotes to understand the contradiction of the increase of medication incident reports and
the reduction in medication safety risks
Theme Category Codes Representive Quotes




based on the IGZ
visits
Reducing emergency supply of medication;
agreement with pharmacy; constructing
medication working groups; agreements
managing and administering medication;
double-checks; training; ‘do not disturb’ logo;
electronic prescribing; transition to another
pharmacy; reformulating protocols
‘We formed a medication working group, with a
board member as chairman, with different kinds
of care professionals.’ (interviewee 10, care
manager)
‘The agreements with the pharmacists on
monitoring medication safety and both their
responsibility, and that of the organisation itself
were reformulated over time.’ (interviewee 10,
care manager)
We received medication from several community
-based pharmacies. We were not at all happy with
that. In the end, we went along with one party.’





Internal audit; form a commission for incident
reports; consultation of pharmacist and general
practitioner; agreement with pharmacy;
(reformulating) guideline reporting incidents;
constructing medication working groups;
electronic prescribing; ‘do not disturb’ logo;
regular training; double-checks
‘One of our focus points was to introduce the
double check on medication and ‘do not disturb’
logos during distribution.’ (interviewee 8, policy
maker)
‘We use coloured jackets with a ‘do not disturb’
logo while distributing medication. However,
psycho geriatric patients may not understand
the meaning of the jackets, and sometimes
ignored them, which can be difficult.’




Referring to guidelines and protocols;
agreement with pharmacy; consultation of
another care facility/location, professional
association, knowledge centre, general
practitioner, pharmacy
‘Furthermore, we consulted pharmacists and
reported on, for example, prescribing behaviour.
Based on this information, we reviewed critically






Willingness; safe culture; clear what to report;
automatic behaviour; no fear; lower threshold
‘It has become automatic. Employees do not have
to worry that they might get punished if they
report an incident. Previously, that feeling
prevailed. That implies we had to reduce the fear
of reporting and to make it clear that it is just an
instrument to improve quality.’ (interviewee 7,
care manager)
‘The barrier to report incidents was reduced. We
saw an abrupt increase in reported errors. But if
improvements are achieved and the quality and
safety of medication is guaranteed, then we will
notice that it actually contributes to reducing
errors.’ (interviewee 4, policy advisor)
The internal causes
of fewer reports
Automated medication dispensing system;
simplified processes; raised awareness;
training; ‘do not disturb’ logo; managing
medication per patient; verbal report
‘We organized training for professionals, to,
among other things, stimulate their awareness
about medication safety.’ (interviewee 1, medical
director)
‘A lot of medication was forgotten, and was not
administered or prepared well. By using the
automated medication dispensing system, quite




Raised awareness; small incidents are reported;
digitisation of reporting; higher complexity of
processes; workload; more complexity of care;
taboo -subject is broken
‘The amount of medication incident reports used
to be very low. But we could not say that nothing
was wrong. We especially concluded: employees
did not report errors. We realised that we had to
stimulate that they would report.’ (interviewee 10,
care manager)
III. Impact of supervision The effects of
the IGZ visits
Focus on details; speeds improvement
processes; stimulates collaboration; raises
awareness; objective judgment; catalyst; makes
funding available
‘The visits of the Health Care Inspectorate causes
alarm bells to ring.’ (interviewee 4, policy advisor)
‘It accelerates the process and made our
medication process very accurate.’ (interviewee 1,
medical director)
‘Also it matters to the board whether the Health
Care Inspectorate indicates improvement is
necessary. It opens doors or makes investments
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Theme 3: The impact of supervision
Two clear categories were identified within this theme:
(1) the effects of the IGZ visits; (2) the lack of effect of
the IGZ visits.
The effects of the IGZ visits
According to most of the interviewees the specific super-
vision of medication safety, in addition to the regular
supervision, had certainly contributed to the awareness
and improvement in medication safety. Care facilities
considered the IGZ as an objective and independent or-
ganisation which had the knowledge and authority to
identify areas of care in which a minimum number of
conditions were required to ensure a high quality. They
view the IGZ was functioning here as a catalyst and was
thus able to speed up improvements, the institutions
considered this supervision as an important boost to
their own activities for improving the quality of care.
The lack of effect of the IGZ visits
Not all interviewees attributed the improvements to the
activities of the Inspectorate. The interviewees men-
tioned that a positive working environment affected the
intrinsic motivation of health care professionals. This
motivation stimulated them to think critically and
thereby to be able to improve their working practices.
Discussion
We aimed, in this study, to understand the paradox
posed by the increase in medication incident reports at
the same time as the reduction in observed risks. Conse-
quently, we aimed to provide insights into whether mon-
itoring the national indicator of medication safety
incidents is an efficient way to identify the impact of
supervision.
However, several implications of the supervision by
the IGZ regarding medication safety in elderly care facil-
ities can be identified. First of all, it suggests that the in-
crease in incidents reported to the national indicator of
medication safety was merely an expression of an in-
creased willingness to report, instead of an expression of
the increased medication risks. From this perspective,
the contradiction between the improvements in medica-
tion safety by supervision and the increased number of
medication incident reports, as mentioned in the intro-
duction, seems to be logical. The willingness to report
might be considered as a sign of a safer culture with re-
gard to medication. However, even though the trend
analyses of the number of incidents showed an alarming
increase, the IGZ should better be cautious in using this
national indicator as a sign of the impact of supervision
of medication safety. After all, the high number of inci-
dents reported was not necessarily an indicator of in-
creased risks. The reactions of the interviewees suggest
that it is in fact the other way around in the sense that
the fewer incidents reported, the higher the risks of
medication errors. Former research has confirmed this
phenomenon. A study into two Australian hospitals by
Westbrook et al. [15] showed that the hospital with the
higher number of incident reports experienced a lower
actual rate of prescribing errors. The researchers con-
cluded that the higher the number of medication inci-
dents means a lower risk to the patient [15].
This study also shows the risks of using self-reported in-
dicators. Several studies have confirmed that self-
reporting can undermine the validity and reliability of data
[16]. This could be explained in part by the small percent-
age of incidents occurring which the health care profes-
sionals actually report [15]. However, even though self-
reported indicators, such as the number of medication
Table 5 Themes, categories, codes and quotes to understand the contradiction of the increase of medication incident reports and
the reduction in medication safety risks (Continued)
possible. Therefore, as professionals, we
sometimes ‘used’ the Inspectorates’ authority to
make necessary changes which we weren’t able
to establish ourselves, unfortunately.’ (interviewee
2, pharmacist, responsible for medication care in
nursing homes)
The lack of effect
of the IGZ visits
Intrinsic motivation; critical employees;
good internal working environment
‘Honestly, I think that most of the improvements
came from ourselves. We wanted things to get
better, so we took care that things were getting
better.’ (interviewee 3, medical director)
‘Did the Inspectorate have any influence on the
willingness to report incidents? I don’t think so. It
is merely an internal development, concerning
how to deal with each other, what is the
management style, how do employees experience
reporting? So I think it is above all an internal
matter. I don’t think the visits or the report of the
IGZ contributed to that change of culture.’
(interviewee 10, care manager)
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incidents, may be unsuitable for indicating the impact of
supervision, these indicators can certainly identify possible
areas for improving safety. Yet, a health care inspectorate
needs indicators with a high predictive value for unsafe or
irresponsible care if it is to be able to explore the impact
of its supervision [17]. For this purpose, a quantified
measure could be developed, based on reliable and valid
data [16].
Thirdly, this study suggests that the thematic supervi-
sion by the IGZ has contributed to a reduction in the
medication risks among the level of health care pro-
viders. Thematic supervision of medication safety re-
sulted in several quality improvement activities, a review
of protocols and a change in culture of reporting inci-
dents. Health care professionals started to realise that
reporting incidents is not about punishing and blaming.
It is, instead, essential for improving the safety of care.
Most care facilities considered this supervision as a use-
ful driving force for improving care safety. Using the ad-
vice of an authority such as the IGZ, meant that most
nursing homes and homes for older people felt stimu-
lated to organise improvement activities and to reduce
the risk of medication incidents.
Strengths and limitations
A limitation of this study is that the relationship be-
tween supervision activities and improvements is hard
to understand. This requires insight into, mostly, com-
plicated external factors. Van Dishoeck et al. [18] de-
signed a theoretical chain of impact which could offer
insight into this process. It explained that supervision
activities can have an affect not just on health plans but
also on the media, citizens, politicians and care unions.
For their part, these stakeholders have an influence upon
the compliance of health care professionals and organi-
sations with the recommendations for improving care
which follow from supervision [19]. Also another study
on the impact of supervision indicated that improved
adherence to guidelines is only partly attributable to a
supervision programme. This programme, based on a
guideline for midwives to counsel pregnant women to
give up smoking, helped to improve counseling by mak-
ing midwives aware of it and giving them an extrinsic
motivation to provide such counseling. However, adher-
ence to guidelines depended on several other factors too.
The most important are motivation and professional and
environmental factors. The impact of supervision on the
quality and safety of health care might be mostly indirect
and limited [18, 20].
Another limitation is that the two researchers were
IGZ- employees. This might have caused social desirabil-
ity bias, that is the tendency of the participants to an-
swer the questions in a favourable manner. Secondly,
this might have caused confirmation bias, that is the
tendency to interpret the information from the inter-
views in a way that confirms the hypotheses of the IGZ
researchers. We tried to limit the impact of these biases
by the participation of the third researcher who was an
external one and who supervised the analysis. Further-
more, we stressed in the introduction to the interviews
that the interviewer was not an inspector with daily
supervision tasks but their role was to work as a re-
searcher for the IGZ. Finally, the participants were told
that the results would be presented anonymously.
A third limitation is that the researchers have not
achieved the stage of theoretical sampling. The selection
was based on data gathered previously by the IGZ.
Therefore, the researchers obtained maximum variation
in the organisations participating by selecting those
which reported an extreme increase or decrease in the
number of reports of medication safety and by, as far as
possible, selecting participants who were involved in the
IGZ visits. By an appropriate subjective selection, satur-
ation was reached after ten interviews.
A final limitation is that only a small number of orga-
nisations offering long-term elderly care were visited.
Therefore, it is hard to draw general conclusions about
these results for all Dutch elderly care facilities. How-
ever, despite the small sample of organisations selected,
we ensured the quality of the research through a variety
of means, such as by using different researchers to en-
sure internal validity, by conducting a member check of
the interviews and by using the COREQ checklist.
Nevertheless, when focusing on evaluating the impact of
supervision, future research should draw on a larger
sample of organisations in order to quantify the results
and draw general conclusions.
However, the mixed method character of this study is
one of its strengths. In addition to the analysis of quanti-
tative data such as the national indicator of medication
safety incidents and the risk calculations by the IGZ, in-
terviews contributed to gaining a better understanding
of the impact of supervision. This helped to explain the
paradox posed by the increase in the number of medica-
tion incident reports. Furthermore, saturation was
reached after ten interviews as almost all interviewees
agreed on the impact of supervision [21].
Implications and future research
The key finding for daily practice of supervision is to be
aware of the risk of using self-reported indicators to as-
sess the effects of supervision. In the Netherlands, as in
many countries, many quality indicators are collected by
organisations themselves. Future research could also use
indicators based on, for example, administrative data to
explore whether the same conclusions could be drawn.
Secondly, the interviewees stated that the visits of the
IGZ worked as a boost or an inducement for actual
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compliance. It would be interesting to explore whether
and how these visits of the IGZ contribute to actual
compliance. For instance, exploring the difference in the
impact on compliance between an advisory and a super-
visory attitude of the inspector during the visit. It would,
furthermore, be interesting to explore, in future re-
search, whether a visit of this external catalyst has more
impact on improving quality as opposed to performing
quality improvements driven by ‘intrinsic motivation’ in
organisations which are not visited.
Finally, the lessons learned from this study could also
be useful for other Dutch supervisory bodies, or health
care inspectorates outside the Netherlands. However, the
differences in supervisory practice should always be
taken into account.
Conclusion
The interviewees indicated that supervision focused on
medication safety, attributed to a transformation in the
policy toward the medication safety of nursing homes and
homes for older people. Most elderly care facilities and
their professionals working for them stated that the IGZ
was a useful catalyst and a driving force for reducing
medication risks. This view was supported by a major de-
cline in risks assessed by the IGZ. They also indicated that
the culture of reporting had changed resulting in more
self- reported medication incidents. Interpreting self-
reported indicators in order to assess the impact of super-
vision should therefore be carried out with caution. An in-
creased number of reported incidents is not necessarily an
indicator of a higher level of risk.
Additional files
Additional file 1: Indicator medication safety incidents year
2007_2008_2009. This file contains self-reported indicators from all care
facilities over the years 2007-2009. The indicator represents the percentage
of patients that encountered a medication incident during the month prior
to the measurement of the indicator. (XLSX 49 kb)
Additional file 2: Indicator medication safety incidents year
2010_2011_2012. This file contains self-reported indicators from all care
facilities over the years 2010-2012. The indicator represents the percentage
of patients that encountered a medication incident during the month prior
to the measurement of the indicator. (XLSX 36 kb)
Additional file 3: Research checklist COREQ. This file contains a 32-item
checklist with consolidated criteria for reporting qualitative studies.
(DOC 67 kb)
Additional file 4: The number of medication safety risks 2010-2011. This
file contains the individual results from the ten care facilities; the number
of medication safety risks observed during the visits of the IGZ. (XLSX 18 kb)
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